- Current report filing (8-K)
05 January 2013 - 8:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date of report (date of earliest event
reported): December 28, 2012
DEHAIER MEDICAL SYSTEMS LIMITED
(Exact name of registrant as specified
in its charter)
British Virgin Islands
|
|
001-34661
|
|
Not Applicable
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
Room 501, 83 Fuxing Road
Haidian District, Beijing 100856
People’s Republic of China
(Address of principal executive
offices)
Registrant’s telephone number,
including area code: (8610) 5166-0080
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.02 DEPARTURE
OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN
OFFICERS.
Items 5.02(b) and 5.02(c)
Effective December 28, 2012, the Registrant announced the internal
promotion of several officers within the company. The following table lists the positions held by each individual before and after
December 28, 2012. All of the changes were effective on December 28, 2012.
Name
|
|
Prior Position
|
|
New Position
|
Aileen Qi
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
Vice President
|
Charles Li
|
|
Internal Controls Manager
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
Jingli (Charles) Li
Chief Finance Executive
Age – 27
With Dehaier since 2010
Mr. Li is very familiar with US GAAP, China GAAP and the Sarbanes-Oxley
Act and has supported Dehaier with the establishment of internal control system and procedures since November 2010. He previously
worked as senior auditor in KPMG Huazhen Beijing from September 2008 through November 2010 with extensive experience in audit
methods and internal controls as well as financial management. Mr. Li earned his bachelor degree in Economics at Beijing University
of Technology in 2008 and is a member of the Internal Control Institute as a Certified Internal Control Specialist.
Yanying (Aileen) Qi
Vice President
Age – 33
With Dehaier since 2004
Ms. Qi is familiar with US GAAP and PRC GAAP
reporting and has assisted Dehaier with the Company’s IPO and ongoing accounting reporting responsibilities. Prior to joining
Dehaier, Ms. Qi served for three years as Financial Manager at Singapore Shoubiao Company Ltd. Ms. Qi earned dual degrees in accounting
and finance at Renmin University in China.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
99.1
|
Press release dated January 4, 2013 titled “Dehaier Medical Announces Management Change.”
|
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DEHAIER MEDICAL SYSTEMS LIMITED
|
|
|
|
|
By:
|
/s/ Ping Chen
|
|
|
Ping Chen
|
|
|
Chief Executive Officer
|
|
Dated: January 4, 2013
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024